相关实验视频
Updated: Jul 9, 2025
10:10
Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
12.7K
阿尔茨海默病的放射治疗:一个系统的审查
David Kaul1, Felix Ehret2, Siyer Roohani2
1Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; German Cancer Consortium (DKTK), Partner Site Berlin, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
International journal of radiation oncology, biology, physics
|December 2, 2023
概括
低剂量辐射疗法 (LDRT) 通过减少粉样质斑块和神经纤维细胞结,对阿尔茨海默病 (AD) 治疗具有前景. 早期的人类试验表明认知和行为改善具有最小的毒性,需要进一步调查.
科学领域:
- 神经学和神经科学 神经学和神经科学
- 辐射瘤学 辐射瘤学
- 药理学和治疗学 药理学和治疗学
背景情况:
- 阿尔茨海默病 (AD) 的特点是粉样斑块和神经纤维状,神经炎症在其进展中发挥着关键作用.
- 低剂量放射治疗 (LDRT) 已成为阿尔茨海默病的潜在治疗干预措施,在临床前和早期临床研究中显示出前景.
结论:
- LDRT为AD提供了一个有希望的治疗途径,影响关键的病理特征,并提供潜在的临床益处.
- 进一步的I/II/III期临床试验对于充分阐明ADLDRT的潜在机制,长期安全性,疗效和最佳治疗参数至关重要.
相关概念视频
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
01:26Alzheimer's Disease: Overview
494
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
494